LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 98 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $816,156 | -5.8% | 356,400 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $866,052 | +2069.5% | 356,400 | +1605.3% | 0.00% | – |
| Q4 2022 | $39,919 | -92.6% | 20,900 | -90.7% | 0.00% | -100.0% |
| Q3 2022 | $538,203 | +591.1% | 224,336 | +436.7% | 0.00% | – |
| Q2 2022 | $77,874 | -11.2% | 41,800 | 0.0% | 0.00% | – |
| Q1 2022 | $87,681 | -70.4% | 41,800 | -44.4% | 0.00% | -100.0% |
| Q4 2021 | $296,000 | -88.7% | 75,200 | -86.8% | 0.00% | -75.0% |
| Q2 2021 | $2,620,000 | +10.9% | 571,000 | +41.9% | 0.00% | -42.9% |
| Q1 2021 | $2,362,000 | +1008.9% | 402,300 | +546.8% | 0.01% | +600.0% |
| Q4 2020 | $213,000 | +180.3% | 62,200 | +61.1% | 0.00% | – |
| Q1 2020 | $76,000 | -93.2% | 38,600 | -85.7% | 0.00% | -100.0% |
| Q4 2019 | $1,118,000 | +120.9% | 269,404 | +60.4% | 0.00% | +100.0% |
| Q3 2019 | $506,000 | -68.7% | 168,000 | -34.7% | 0.00% | -66.7% |
| Q2 2019 | $1,618,000 | +413.7% | 257,200 | +354.4% | 0.00% | +200.0% |
| Q1 2019 | $315,000 | – | 56,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 71,178,364 | $280,443,000 | 7.61% |
| BVF INC/IL | 14,360,000 | $56,578,000 | 2.05% |
| Integral Health Asset Management, LLC | 200,000 | $788,000 | 0.22% |
| Eversept Partners, LP | 797,694 | $3,142,914 | 0.20% |
| NEA Management Company, LLC | 2,382,286 | $9,386,000 | 0.19% |
| PINNACLE ASSOCIATES LTD | 2,127,662 | $8,383,000 | 0.14% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $141,000 | 0.06% |
| Virtus ETF Advisers LLC | 41,584 | $164,000 | 0.06% |
| Pegasus Asset Management, Inc. | 10,000 | $39,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 31,562 | $124,000 | 0.02% |